1. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
   Yukihiro Haruyama, 2016, World Journal of Gastroenterology CrossRef
2. Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
   Yasuo Tanaka et al, 2018, International Journal of Molecular Sciences CrossRef
3. Next-Generation Cancer Immunotherapy Targeting Glypican-3
   Yasuhiro Shimizu et al, 2019, Frontiers in Oncology CrossRef